Editorial Expression of Concern: Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
Year: 2025
Type: article
Language: en
Topic: 14-3-3 protein interactions
Authors and affiliations:
raw_author_name: Yang Li
raw_affiliation_strings: Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
raw_author_name: Lihua Zou
raw_affiliation_strings: Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA
Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
raw_author_name: Qiyuan Li
raw_affiliation_strings: Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
raw_author_name: Benjamin Haibe-Kains
raw_affiliation_strings: Machine Learning Group, Université Libre de Bruxelles, Brussels, Belgium
Medical Oncology Department, Jules Bordet Institute, Brussels, Belgium
raw_author_name: Ruiyang Tian
raw_affiliation_strings: Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
raw_author_name: Yan Li
raw_affiliation_strings: Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
raw_author_name: Christine Desmedt
raw_affiliation_strings: Medical Oncology Department, Jules Bordet Institute, Brussels, Belgium
raw_author_name: Christos Sotiriou
raw_affiliation_strings: Medical Oncology Department, Jules Bordet Institute, Brussels, Belgium
raw_author_name: Zoltan Szallasi
raw_affiliation_strings: Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark
Children's Hospital Informatics Program at the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts, USA
raw_author_name: J. Dirk Iglehart
raw_affiliation_strings: Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
raw_author_name: Andrea L. Richardson
raw_affiliation_strings: Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. arichardson@partners.org
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. arichardson@partners.org
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
raw_author_name: Zhigang Charles Wang
raw_affiliation_strings: Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. zhigang_wang@dfci.harvard.edu
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. zhigang_wang@dfci.harvard.edu
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA